HELLP Syndrome, a severe form of preeclampsia: a comparative study of clinical and laboratorial parameters

Ana Correia Campos

Abstract


The objective of this study was to compare clinical, laboratorial, maternal and perinatal results between HELLP Syndrome and severe Preeclampsia. An observational study comparing women with HELLP Syndrome (n=71) to women with severe preeclampsia (n=253) was done. The authors analyzed the early course of the pathologies and the outcomes in both groups. HELLP syndrome occurred in 28% of all the cases and was more frequent at gestational age before 32 weeks (n=39 – 55%) than severe preeclampsia (n=108 - 42%), with more newborns weighting less than 1500g (27 – 38.6% vs 65 – 25.6%; p=0.036). Thrombocytopenia below 100 000/µL (aOR, 2.14; 95% CI, 1.49 – 3.06) and LDH>1 000 UI/L (aOR: 5.17; 95% CI 2.19 – 12.16) were risk factors for HELLP. Maternal morbidity (eclampsia, abruptio placentae, and acute renal failure) was similar in both cohorts; eight stillbirths (6 in severe preeclampsia and 2 in HELLP Syndrome) occurred. There were no maternal deaths. In conclusion, in this study the authors confirmed that HELLP Syndrome is a severe form of preeclampsia with an earlier presentation in pregnancy, worst laboratorial findings and more prematurity rates.


Keywords


Preeclampsia, thrombocytopenia, maternal and perinatal morbidity, HELLP syndrome

Full Text:

PDF

References


Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 365: 785-99, 2005.

Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet. Gynecol 180: 499-506, 1999.

Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethyl-arginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361: 1511-1517, 2003.

Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet. Gynecol 142: 159-167, 1982.

Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet. Gynecol 155: 501-509, 1986.

Barton JR, Sibai BM: Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin. Perinatol 31: 807-833, 2004.

Dadelszen P, Payne B, Li J, Ansermino JM, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 377: 219-227, 2011.

Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth 9: 8, 2009.

Martin JN. Milestones in the quest for best management of patients with HELLP syndrome (microangiopathic hemolytic anemia, hepatic dysfunction, thrombocytopenia). Int J Gynecol Obstet 121: 202-207, 2013

Abildgaard U, Heimdal K. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol 166: 117-123, 2013

Report of the National High Blood Pressure Education Program.Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 183: S1-22, 2000

American College of Obstetricians and Gynecologists.Taskforce on Hypertension in Pregnancy. Hypertension in Pregnancy/Developed by the Task Force on Hypertension in Pregnancy (2013) ACOG.

Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103: 981-991, 2004.

Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169(4): 1000-1006, 1993.

Sep S, Verbeek J, Koek G, et al. Clinical differences between early-onset HELLP syndrome and early-onset preeclampsia during pregnancy and at least 6 months postpartum. Am J Obstet Gynecol 202: 271.e1-5, 2010.

Fitzpatrick K E., Hinshaw K, Kurinczuk J J., Knight M. Risk Factors, Management, and Outcomes of Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome and Elevated Liver Enzymes, Low Platelets Syndrome. Obstet Gynecol 123: 618-127, 2014.

Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: Clinical issues and management.A Review. BMC Pregnancy Childbirth 9: 8, 2009.

Wallace K, Martin JN Jr, Tam K, et al. Seeking the mechanism(s) of action for corticosteroids in HELLP syndrome: SMASH study. Am J Obstet Gynecol 208: 380.e1-8, 2013.

Sep S, Verbeek J, Koek G, et al. Clinical differences between early-onset HELLP syndrome and early-onset preeclampsia during pregnancy and at least 6 months postpartum. Am J Obstet Gynecol 202: 271.e1-5, 2010.


Refbacks

  • There are currently no refbacks.